131 related articles for article (PubMed ID: 12639966)
21. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.
Lasek AL; McPherson BM; Trueman NG; Burkard ME
PLoS One; 2016; 11(2):e0150225. PubMed ID: 26919439
[TBL] [Abstract][Full Text] [Related]
22. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.
Toyoshima-Morimoto F; Taniguchi E; Shinya N; Iwamatsu A; Nishida E
Nature; 2001 Mar; 410(6825):215-20. PubMed ID: 11242082
[TBL] [Abstract][Full Text] [Related]
23. The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles.
Guarguaglini G; Duncan PI; Stierhof YD; Holmström T; Duensing S; Nigg EA
Mol Biol Cell; 2005 Mar; 16(3):1095-107. PubMed ID: 15616186
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation- and polo-box-dependent binding of Plk1 to Bub1 is required for the kinetochore localization of Plk1.
Qi W; Tang Z; Yu H
Mol Biol Cell; 2006 Aug; 17(8):3705-16. PubMed ID: 16760428
[TBL] [Abstract][Full Text] [Related]
25. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.
Spänkuch B; Matthess Y; Knecht R; Zimmer B; Kaufmann M; Strebhardt K
J Natl Cancer Inst; 2004 Jun; 96(11):862-72. PubMed ID: 15173270
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.
Serafim RAM; Sorrell FJ; Berger BT; Collins RJ; Vasconcelos SNS; Massirer KB; Knapp S; Bennett J; Fedorov O; Patel H; Zuercher WJ; Elkins JM
J Med Chem; 2021 Sep; 64(18):13259-13278. PubMed ID: 34463505
[TBL] [Abstract][Full Text] [Related]
27. Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.
Higashimoto T; Chan N; Lee YK; Zandi E
J Biol Chem; 2008 Dec; 283(51):35354-67. PubMed ID: 18957422
[TBL] [Abstract][Full Text] [Related]
28. B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.
Zhang H; Shi X; Paddon H; Hampong M; Dai W; Pelech S
J Biol Chem; 2004 Aug; 279(34):35726-34. PubMed ID: 15190079
[TBL] [Abstract][Full Text] [Related]
29. The family of polo-like kinases.
Golsteyn RM; Lane HA; Mundt KE; Arnaud L; Nigg EA
Prog Cell Cycle Res; 1996; 2():107-14. PubMed ID: 9552388
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
31. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
32. Heterologous expression of mammalian Plk1 in Drosophila reveals divergence from Polo during late mitosis.
Pearson J; Godinho SA; Tavares A; Glover DM
Exp Cell Res; 2006 Apr; 312(6):770-81. PubMed ID: 16412419
[TBL] [Abstract][Full Text] [Related]
33. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
Moshe Y; Boulaire J; Pagano M; Hershko A
Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.
Elia AE; Rellos P; Haire LF; Chao JW; Ivins FJ; Hoepker K; Mohammad D; Cantley LC; Smerdon SJ; Yaffe MB
Cell; 2003 Oct; 115(1):83-95. PubMed ID: 14532005
[TBL] [Abstract][Full Text] [Related]
35. Functional independency between catalytic activity and subcellular targeting of polo-like kinase-1: phenotypes of ectopic overexpression of various mutants.
Ji JH; Jang YJ
Cell Cycle; 2008 Jun; 7(11):1597-603. PubMed ID: 18560274
[TBL] [Abstract][Full Text] [Related]
36. The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.
Tsvetkov LM; Tsekova RT; Xu X; Stern DF
Cell Cycle; 2005 Apr; 4(4):609-17. PubMed ID: 15876876
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.
Neef R; Preisinger C; Sutcliffe J; Kopajtich R; Nigg EA; Mayer TU; Barr FA
J Cell Biol; 2003 Sep; 162(5):863-75. PubMed ID: 12939256
[TBL] [Abstract][Full Text] [Related]
38. Purification and cloning of a protein kinase that phosphorylates and activates the polo-like kinase Plx1.
Qian YW; Erikson E; Maller JL
Science; 1998 Nov; 282(5394):1701-4. PubMed ID: 9831560
[TBL] [Abstract][Full Text] [Related]
39. JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1.
Ramkumar P; Lee CM; Moradian A; Sweredoski MJ; Hess S; Sharrocks AD; Haines DS; Reddy EP
J Biol Chem; 2015 Dec; 290(49):29617-28. PubMed ID: 26468278
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD.
Jang MS; Lee SJ; Kim CJ; Lee CW; Kim E
Oncogene; 2011 Jan; 30(4):471-81. PubMed ID: 20890306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
